Each year sees the advent of new ophthalmic drugs, only a few of which are worthy of a permanent place in the ophthalmologist's cabinet. Among these are certain concentrated solutions of epinephrine or synthetic preparations of a similar nature which seem to be proving of real value in selected cases of glaucoma.
It was my intention to review fully the history of the introduction and use of these drugs because such a review has not appeared in English, but it has recently been so excellently carried out in German by Thiel1 and also by Peters2 that my analysis would be scarcely more than a translation from these authors and as such seems hardly worth while. Suffice it to record here that soon after the isolation of the active principle of the suprarenals many ophthalmologists began to study its effect on the eye, and to mention briefly some
POST LT. LAEVO-GLAUKOSAN AND EPINEPHRINE BITARTRATE IN THE TREATMENT OF GLAUCOMA. Arch Ophthalmol. 1934;11(1):187–193. doi:10.1001/archopht.1934.00830080195021
Ophthalmology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.